Closed dhimmel closed 1 year ago
If we go with "metapath" to refer to 1, here are some possibilities for 2:
I don't love any of the above options. @kkloste @bdsullivan @mmayers12: are you familiar with any terms of art that could help us differentiate 1 and 2.
We never created any terminology that is more succinct than the explicit long forms here.
Suggestions or insights still welcome below.
The following concepts play a crucial role in this study:
metapath instance: referring to a type of path such as Compound–downregulates–Gene–participates–Molecular Function (CdGpMF). This concept is defined a sequence of metaedges.
source-metapath-target instance: referring to a type of path between two specific nodes, such as Raltitrexed–downregulates–Gene–participates–histone serine kinase activity. This concept is defined a sequence of metaedges with the a specific source and target node.
source-path-target instance: referring to a path between two specific nodes, such as Raltitrexed – downregulates – AURKB – participates – histone serine kinase activity. This concept is defined a sequence of edges.
I think we can refer to 3 as a path, and there won't be confusion because paths are generally understood as traversing specific nodes & edges, hence implying specific source and target nodes.
1 & 2 are more prone to confusion. In 1, we're referring to an abstract type of path, before selecting a specific source and target node. 2 is also a metapath, but now refers to the specific connectivity between two nodes (source and target).